- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Deferred Tax Assets and Liabilities, Classification
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Total Asset Turnover
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Income Tax Expense (Benefit)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Item | Description | The company |
---|---|---|
Current taxes | Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. | Cigna Group current taxes decreased from 2022 to 2023 and from 2023 to 2024. |
Deferred tax benefits | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. | Cigna Group deferred tax benefits decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level. |
Income taxes | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | Cigna Group income taxes decreased from 2022 to 2023 but then increased from 2023 to 2024 not reaching 2022 level. |
Effective Income Tax Rate (EITR)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Item | Description | The company |
---|---|---|
Effective income tax rate | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | Cigna Group effective income tax rate decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level. |
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Item | Description | The company |
---|---|---|
Deferred tax assets before valuation allowance | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | Cigna Group deferred tax assets before valuation allowance increased from 2022 to 2023 and from 2023 to 2024. |
Deferred tax assets, net of valuation allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | Cigna Group deferred tax assets, net of valuation allowance increased from 2022 to 2023 but then slightly decreased from 2023 to 2024. |
Net deferred income tax assets (liabilities) per Consolidated Balance Sheets | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. | Cigna Group net deferred income tax assets (liabilities) per Consolidated Balance Sheets increased from 2022 to 2023 and from 2023 to 2024. |
Deferred Tax Assets and Liabilities, Classification
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Deferred tax assets (reported in Other assets) | 893) | 1,055) | —) | —) | —) | |
Deferred tax liabilities | 6,975) | 7,242) | 7,751) | 8,346) | 8,939) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Item | Description | The company |
---|---|---|
Deferred tax assets (reported in Other assets) | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting and classified as noncurrent. | Cigna Group deferred tax assets (reported in Other assets) increased from 2022 to 2023 but then slightly decreased from 2023 to 2024. |
Deferred tax liabilities | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent. | Cigna Group deferred tax liabilities decreased from 2022 to 2023 and from 2023 to 2024. |
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Cigna Group, Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Financial ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by total revenue. | Cigna Group adjusted net profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Adjusted total asset turnover | An activity ratio calculated as total revenue divided by adjusted total assets. | Cigna Group adjusted total asset turnover ratio improved from 2022 to 2023 and from 2023 to 2024. |
Adjusted financial leverage | A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income. |
Cigna Group adjusted financial leverage ratio increased from 2022 to 2023 and from 2023 to 2024. |
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by adjusted shareholders’ equity. | Cigna Group adjusted ROE deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by adjusted total assets. | Cigna Group adjusted ROA deteriorated from 2022 to 2023 and from 2023 to 2024. |
Cigna Group, Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Net profit margin = 100 × Shareholders’ net income ÷ Revenues from external customers
= 100 × 3,434 ÷ 246,148 = 1.40%
2 Adjusted net profit margin = 100 × Adjusted shareholders’ net income ÷ Revenues from external customers
= 100 × 3,339 ÷ 246,148 = 1.36%
Profitability ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by total revenue. | Cigna Group adjusted net profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Total asset turnover = Revenues from external customers ÷ Total assets
= 246,148 ÷ 155,881 = 1.58
2 Adjusted total asset turnover = Revenues from external customers ÷ Adjusted total assets
= 246,148 ÷ 154,988 = 1.59
Activity ratio | Description | The company |
---|---|---|
Adjusted total asset turnover | An activity ratio calculated as total revenue divided by adjusted total assets. | Cigna Group adjusted total asset turnover ratio improved from 2022 to 2023 and from 2023 to 2024. |
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Financial leverage = Total assets ÷ Shareholders’ equity
= 155,881 ÷ 41,033 = 3.80
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted shareholders’ equity
= 154,988 ÷ 47,115 = 3.29
Solvency ratio | Description | The company |
---|---|---|
Adjusted financial leverage | A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income. |
Cigna Group adjusted financial leverage ratio increased from 2022 to 2023 and from 2023 to 2024. |
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROE = 100 × Shareholders’ net income ÷ Shareholders’ equity
= 100 × 3,434 ÷ 41,033 = 8.37%
2 Adjusted ROE = 100 × Adjusted shareholders’ net income ÷ Adjusted shareholders’ equity
= 100 × 3,339 ÷ 47,115 = 7.09%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by adjusted shareholders’ equity. | Cigna Group adjusted ROE deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROA = 100 × Shareholders’ net income ÷ Total assets
= 100 × 3,434 ÷ 155,881 = 2.20%
2 Adjusted ROA = 100 × Adjusted shareholders’ net income ÷ Adjusted total assets
= 100 × 3,339 ÷ 154,988 = 2.15%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by adjusted total assets. | Cigna Group adjusted ROA deteriorated from 2022 to 2023 and from 2023 to 2024. |